跳至主要内容
临床试验/NCT02346942
NCT02346942已完成不适用

Factors Associated With Biologic Disease Modifying Antirheumatic Drugs Switching and Impact of Healthcare Resource Utilization in a Managed Care Setting

Bristol-Myers Squibb0 个研究点目标入组 4,099 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,099
主要终点
Measure the change in population of patients who are treated with first- or second-line bDMARD therapy (with or without Methotrexate) to another bDMARD therapy

研究概览

简要总结

The Primary objective of this study is to understand the rheumatoid arthritis (RA) population in national integrated delivery network who are treated with first- or second-line biologic disease modifying anti-rheumatic drug (bDMARD) therapy (with or without Methotrexate) and to evaluate switching patterns and reasons for switching to another bDMARD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of RA (ICD-9 714.xx) anytime during the study time period of 1/1/2007 to 10/31/2012
  • Patients ≥18 years of age at diagnosis date
  • Required to have to have 6 months pre-index and 12 months post-index continuous membership and drug benefit eligibility in the database

排除标准

  • Patients less than 18 years of age on diagnosis date
  • If they had a diagnosis of Crohn's disease, psoriasis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, regional enteritis, or anal fistula during the pre-index period
  • Patients who had <7 days supply of adalimumab or etanercept
  • Patients currently in a clinical trial during our study
  • If patients are in the second-line cohort and have more than 1 prior bDMARD

结局指标

主要结局

Measure the change in population of patients who are treated with first- or second-line bDMARD therapy (with or without Methotrexate) to another bDMARD therapy

时间窗: Approximately 6 months

Measure the reasons for switching to another bDMARD based on Provider documentation in chart notes

时间窗: 6 months pre-index date

次要结局

  • Evaluate RA related and all cause healthcare resource utilization of doctor visits, hospitalizations and ER visits as patients switch bDMARDs measured from Patient heath claims data from KPSC integrated healthcare data(6 month pre-index and 6 months pre-index date and 12 month post index follow up)

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

相似试验